Common Genetic Factors in Autoimmunity;Factores genéticos comunes en autoinmunidad

Reumatologia Clinica Suplementos

Volumn 4, Issue SUPPL. 1, 2008, Pages 1-4

  Rueda, Blanca ^a   Orozco, Gisela ^a   Sánchez, Elena ^a   Oliver, Javier ^a   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Chondrocyte differentiation; Osteoarthritis; Skeletal morphogenesis

Indexed keywords

EID: 44449167281     PISSN: 18863604     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med. 2006;12:90-8.
2. Rioux JD, Abbas AK. Paths to understanding the genetic basis of autoimmune disease. Nature. 2005;435:584-9.
3. Becker KG. The common genetic hypothesis of autoimmune/inflammatory disease. Curr Opin Allergy Clin Immunol. 2001;1:399-405.
4. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol. 2001;2:802-9.
5. Yamada R, Ymamoto K. Recent findings on genes associated with inflammatory disease. Mutat Res. 2005;573:136-51.
6. Aune TM, Maas K, Parker J, Moore JH, Olsen NJ. Profiles of gene expression in human autoimmune disease. Cell Biochem Biophys. 2004;40:81-96.
7. Rose N, Mackay IR. The autoimmune diseases. London: Academy Press; 1999.
8. Cordell HJ, Clayton DG. Genetic association studies. Lancet. 2005;366:1121-31.
9. Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin Immunol. 2006;18:214-23.
10. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36:337-8.
11. Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol. 2006;18:207-13.
12. Orozco G, Sanchez E, Gonzalez-Gay MA, Lopez-Nevot MA, Torres B, Caliz R, et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 2005;52:219-24.
13. Gregersen PK, Bucala R. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum. 2003;48:1171-6.
14. Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005;52:3020-9.
15. Martinez A, Orozco G, Varade J, Sanchez Lopez M, Pascual D, Balsa A, Garcia A, et al. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol. 2007;68:744-7.
16. Nunez C, Rueda B, Martinez A, Lopez-Nevot MA, Fernandez-Arquero M, de la Concha EG, et al. Involvement of macrophage migration inhibitory factor gene in celiac disease susceptibility. Genes Immun. 2007;8:168-70.
17. Sanchez E, Gomez LM, Lopez-Nevot MA, Gonzalez-Gay MA, Sabio JM, Ortego-Centeno N, De Ramon E, et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun. 2006;7:433-6.
18. Oliver J, Marquez A, Gomez-Garcia M, Martinez A, Mendoza JL, Vilchez JR, et al. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut. 2007;56:150-1.
19. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006;6:644-58.
20. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet. 2005;76:528-37.
21. Graham R, Kozyrev S, Baechler E, Reddy P, Plenge R, Bauer J, et al. A common haplotype of interferon regulatory factor 5 (IRF-5) regulates mRNA splicing and expression, and is associated with increased genetic risk in human SLE. Nat Genet. 2006;38:550-5.
22. Kozyrev SV, Lewen S, Reddy PM, et al; Argentine Collaborative Group. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum. 2007;56:1234-41.
23. Rueda B, Reddy MV, Gonzalez-Gay MA, Balsa A, Pascual-Salcedo D, Petersson IF, et al. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum. 2006;54:3815-9.
24. Sigurdsson S, Padyukov L, Kurreeman FA, Liljedahl U, Wiman AC, Alfredsson L, et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum. 2007;56:2202-10.
25. Qu HQ, Marchand L, Grabs R, Polychronakos C. The IRF5 polymorphism in type 1 diabetes. J Med Genet. 2007;44:670-2.
26. Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, et al. An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases [Epub ahead of print]. Hum Mol Genet. 2007; doi:10.1093/hmg/ddm259.